help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wolden-Hanson, T.
Right arrow Articles by Rasmussen, D. D
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wolden-Hanson, T.
Right arrow Articles by Rasmussen, D. D
Endocrinology Vol. 141, No. 2 487-497
Copyright © 2000 by The Endocrine Society

ARTICLES

Daily Melatonin Administration to Middle-Aged Male Rats Suppresses Body Weight, Intraabdominal Adiposity, and Plasma Leptin and Insulin Independent of Food Intake and Total Body Fat1

T. Wolden-Hanson, D. R. Mitton, R. L. McCants, S. M. Yellon, C. W. Wilkinson, A. M. Matsumoto and D. D Rasmussen

Veterans Administration Puget Sound Health Care System and University of Washington (T.W.-H., D.R.M., R.L.M., C.W.W., A.M.M., D.D.R.), Seattle, Washington 98195; and Loma Linda University (S.M.Y.), Loma Linda, California 92350

Address all correspondence and requests for reprints to: Dr. Dennis D. Rasmussen, Research Service (151), Veterans Administration Medical Center, American Lake, Tacoma, Washington 98493. E-mail: drasmuss{at}u.washington.edu

Pineal melatonin secretion declines with aging, whereas visceral fat, plasma insulin, and plasma leptin tend to increase. We have previously demonstrated that daily melatonin administration at middle age suppressed male rat intraabdominal visceral fat, plasma leptin, and plasma insulin to youthful levels; the current study was designed to begin investigating mechanisms that mediate these responses. Melatonin (0.4 µg/ml) or vehicle was administered in the drinking water of 10-month-old male Sprague Dawley rats (18/treatment) for 12 weeks. Half (9/treatment) were then killed, and the other half were submitted to cross-over treatment for an additional 12 weeks. Twelve weeks of melatonin treatment decreased (P < 0.05) body weight (BW; by 7% relative to controls), relative intraabdominal adiposity (by 16%), plasma leptin (by 33%), and plasma insulin (by 25%) while increasing (P < 0.05) locomotor activity (by 19%), core body temperature (by 0.5 C), and morning plasma corticosterone (by 154%), restoring each of these parameters toward more youthful levels. Food intake and total body fat were not changed by melatonin treatment. Melatonin-treated rats that were then crossed over to control treatment for a further 12 weeks gained BW, whereas control rats that were crossed to melatonin treatment lost BW, but food intake did not change in either group. Feed efficiency (grams of BW change per g cumulative food intake), a measure of metabolic function, was negative in melatonin-treated rats and positive in control rats before cross-over (P < 0.001); this relationship was reversed after cross-over (P < 0.001). Thus, melatonin treatment in middle age decreased BW, intraabdominal adiposity, plasma insulin, and plasma leptin, without altering food intake or total adiposity. These results suggest that the decrease in endogenous melatonin with aging may alter metabolism and physical activity, resulting in increased BW, visceral adiposity, and associated detrimental metabolic consequences.




This article has been cited by other articles:


Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
D. Acuna-Castroviejo
A new guest playing with bone and fat
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2007; 292(6): R2206 - R2207.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Sanchez-Hidalgo, Z. Lu, D.-X. Tan, M. D. Maldonado, R. J. Reiter, and R. I. Gregerman
Melatonin inhibits fatty acid-induced triglyceride accumulation in ROS17/2.8 cells: implications for osteoblast differentiation and osteoporosis
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2007; 292(6): R2208 - R2215.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Biol.Home page
S. Bertrand, B. Faivre, and G. Sorci
Do carotenoid-based sexual traits signal the availability of non-pigmentary antioxidants?
J. Exp. Biol., November 15, 2006; 209(22): 4414 - 4419.
[Abstract] [Full Text] [PDF]

Home page
 J ANIM SCIHome page
P. R. Buff, C. D. Morrison, V. K. Ganjam, and D. H. Keisler
Effects of short-term feed deprivation and melatonin implants on circadian patterns of leptin in the horse
J Anim Sci, May 1, 2005; 83(5): 1023 - 1032.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
M. I. C. Alonso-Vale, S. Andreotti, S. B. Peres, G. F. Anhe, C. das Neves Borges-Silva, J. C. Neto, and F. B. Lima
Melatonin enhances leptin expression by rat adipocytes in the presence of insulin
Am J Physiol Endocrinol Metab, April 1, 2005; 288(4): E805 - E812.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
B. Prunet-Marcassus, M. Desbazeille, A. Bros, K. Louche, P. Delagrange, P. Renard, L. Casteilla, and L. Penicaud
Melatonin Reduces Body Weight Gain in Sprague Dawley Rats with Diet-Induced Obesity
Endocrinology, December 1, 2003; 144(12): 5347 - 5352.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
F. Kreier, A. Yilmaz, A. Kalsbeek, J. A. Romijn, H. P. Sauerwein, E. Fliers, and R. M. Buijs
Hypothesis: Shifting the Equilibrium From Activity to Food Leads to Autonomic Unbalance and the Metabolic Syndrome
Diabetes, November 1, 2003; 52(11): 2652 - 2656.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
V. N. Anisimov
Effects of Exogenous Melatonin--A Review
Toxicol Pathol, October 1, 2003; 31(6): 589 - 603.
[Abstract] [PDF]

Home page
 Hum Exp ToxicolHome page
G Aydin, N Ozcelik, E Cicek, and M Soyoz
Histopathologic changes in liver and renal tissues induced by Ochratoxin a and melatonin in rats
Human and Experimental Toxicology, July 1, 2003; 22(7): 383 - 391.
[Abstract] [PDF]

Home page
 J. Nutr.Home page
L. van Hanswijck de Jonge, G. Waller, and N. Stettler
Ethnicity Modifies Seasonal Variations in Birth Weight and Weight Gain of Infants
J. Nutr., May 1, 2003; 133(5): 1415 - 1418.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
B. J. Black Jr., C. A. McMahan, E. J. Masoro, Y. Ikeno, and M. S. Katz
Senescent terminal weight loss in the male F344 rat
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2003; 284(2): R336 - R342.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
F. Zalatan, J. A. Krause, and D. E. Blask
Inhibition of Isoproterenol-Induced Lipolysis in Rat Inguinal Adipocytes in Vitro by Physiological Melatonin via a Receptor-Mediated Mechanism
Endocrinology, September 1, 2001; 142(9): 3783 - 3790.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
F. DABBENI-SALA, S. DI SANTO, D. FRANCESCHINI, S. D. SKAPER, and P. GIUSTI
Melatonin protects against 6-OHDA-induced neurotoxicity in rats: a role for mitochondrial complex I activity
FASEB J, January 1, 2001; 15(1): 164 - 170.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2000 by The Endocrine Society